Nutritional status of children during treatment for acute lymphoblastic leukemia in Guatemala

Federico Antillon1, Emanuela Rossi, Ana Lucia Molina

  • 1Unidad Nacional de Oncologia Pediatrica, Guatemala City, Guatemala.

Pediatric Blood & Cancer
|October 31, 2012
PubMed

Insights

Malnutrition is common in children with acute lymphoblastic leukemia (ALL) in Guatemala. Improving nutritional status during treatment significantly increases survival chances for these young cancer patients.

Area of Science:

  • Pediatric Oncology
  • Global Health
  • Nutritional Science

Background:

  • Malnutrition affects up to 50% of children with cancer in developing nations.
  • This study investigates malnutrition in Guatemalan children diagnosed with acute lymphoblastic leukemia (ALL).

Purpose of the Study:

  • To determine the prevalence and severity of malnutrition at diagnosis and during chemotherapy.
  • To assess the impact of nutritional status on treatment outcomes in pediatric ALL.

Main Methods:

  • Nutritional status (NS) assessed using triceps skin fold thickness (TSFT) and mid-upper arm circumference (MUAC).
  • Classified as adequately nourished (A), moderately depleted (MD), or severely depleted (SD).
  • Evaluations conducted at diagnosis, and at 3 and 6 months of chemotherapy.

Main Results:

  • At diagnosis, 41.5% were severely depleted (SD) and 11.6% moderately depleted (MD).
  • After 6 months, severe depletion decreased to 17.7%, with 76.0% adequately nourished.
  • Severe depletion at 6 months increased the hazard of death by 2.4-fold.

Conclusions:

  • Malnutrition is highly prevalent in newly diagnosed pediatric ALL patients in Guatemala.
  • Severe nutritional depletion predicts therapy abandonment and relapse.
  • Improved nutritional status during the first 6 months enhances survival rates, approaching those without initial depletion.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...